POSTERS ASCO 2024

Cáncer genitourinario

Riñon y vejiga

Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4).

Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4).

Abstract: 4592 Poster Bd #: 287

Poster

Descargar

Autor
Ovidio Fernández Calvo, MD; PhD

Medical Oncology Department-Complejo Hospitalario Universitario de Ourense

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON